Success Metrics

Clinical Success Rate
85.4%

Based on 82 completed trials

Completion Rate
85%(82/96)
Active Trials
1(1%)
Results Posted
28%(23 trials)
Terminated
14(12%)

Phase Distribution

Ph phase_1
18
15%
Ph phase_2
17
14%
Ph phase_3
2
2%
Ph not_applicable
2
2%
Ph early_phase_1
1
1%

Phase Distribution

19

Early Stage

17

Mid Stage

2

Late Stage

Phase Distribution40 total trials
Early Phase 1First-in-human
1(2.5%)
Phase 1Safety & dosage
18(45.0%)
Phase 2Efficacy & side effects
17(42.5%)
Phase 3Large-scale testing
2(5.0%)
N/ANon-phased studies
2(5.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

79.6%

82 of 103 finished

Non-Completion Rate

20.4%

21 ended early

Currently Active

1

trials recruiting

Total Trials

120

all time

Status Distribution
Active(1)
Completed(82)
Terminated(21)
Other(16)

Detailed Status

Completed82
unknown16
Terminated14
Withdrawn7
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
120
Active
1
Success Rate
85.4%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (2.5%)
Phase 118 (45.0%)
Phase 217 (42.5%)
Phase 32 (5.0%)
N/A2 (5.0%)

Trials by Status

withdrawn76%
recruiting11%
terminated1412%
completed8268%
unknown1613%

Recent Activity

1 active trials
Showing 5 of 120
recruiting

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

NCT00897117
completed

Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study

NCT03836417
completedphase_2

Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

NCT01149850
completed

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

NCT01344837
completedphase_1

Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes

NCT00382200
View all 120 trials

Clinical Trials (120)

Showing 20 of 120 trialsScroll for more
NCT00897117

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

Recruiting
NCT03836417

Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study

Completed
NCT01149850Phase 2

Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

Completed
NCT01344837

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Completed
NCT00382200Phase 1

Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes

Completed
NCT00486356Phase 1

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Completed
NCT00520767Phase 2

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

Completed
NCT00736450Early Phase 1

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Terminated
NCT01336933Phase 2

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Completed
NCT00503880Phase 1

Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes

Terminated
NCT00387400Phase 1

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Completed
NCT00788125Phase 1

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Terminated
NCT01332279Phase 1

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Withdrawn
NCT00900055

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

Completed
NCT00481403

Study of Sperm Molecular Factors Implicated in Male Fertility

Completed
NCT00769327Phase 2

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Completed
NCT00898092

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

Unknown
NCT00700778Not Applicable

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

Terminated
NCT01075321Phase 1

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Completed
NCT00601289Phase 2

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Withdrawn

Drug Details

Intervention Type
GENETIC
Total Trials
120